Vantage logo

Sanofi goes back to Scribe

The latest deal focuses on in vivo Crispr editing for sickle cell disease, and follows last year’s cancer collaboration.

Vantage logo

Novo makes a gene editing move

Today’s collaboration with Life Edit is a return to the Danish group’s familiar small, early-stage deal strategy.